June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Müller Cells Changes in Diabetic Macular Edema: Molecular Biomarkers in Regressing Cases
Author Affiliations & Notes
  • Edoardo Midena
    Department of Ophthalmology, University of Padova, Padova, Italy
    GB Bietti Foundation, IRCCS, Roma, Italy
  • Silvia Bini
    Department of Ophthalmology, University of Padova, Padova, Italy
  • Alessandra Micera
    GB Bietti Foundation, IRCCS, Roma, Italy
  • Graziana Esposito
    GB Bietti Foundation, IRCCS, Roma, Italy
  • Marianna Berton
    Department of Ophthalmology, University of Padova, Padova, Italy
  • Raffaele Parrozzani
    GB Bietti Foundation, IRCCS, Roma, Italy
  • Elisabetta Pilotto
    Department of Ophthalmology, University of Padova, Padova, Italy
  • Stela Vujosevic
    Department of Ophthalmology, University of Padova, Padova, Italy
  • Footnotes
    Commercial Relationships Edoardo Midena, None; Silvia Bini, None; Alessandra Micera, None; Graziana Esposito, None; Marianna Berton, None; Raffaele Parrozzani, None; Elisabetta Pilotto, None; Stela Vujosevic, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4713. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Edoardo Midena, Silvia Bini, Alessandra Micera, Graziana Esposito, Marianna Berton, Raffaele Parrozzani, Elisabetta Pilotto, Stela Vujosevic; Müller Cells Changes in Diabetic Macular Edema: Molecular Biomarkers in Regressing Cases . Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4713. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To correlate some specific biomarkers of Müller cells activation in diabetic eyes with regressing versus persistent diabetic macular edema (DME).

Methods: Twenty-six diabetic eyes with regressing diabetic macular edema (DME) were compared with 26 persistent DME eyes, and 20 diabetic eyes without DME. Aqueous humor was sampled in all eyes using a 30 gauge needle through a peripheral clear cornea approach. Each subject underwent full ophthalmic examination, and SD-OCT retinal layers segmentation, before aqueous humor sampling. Each sample was analyzed to quantify: glial fibrillary acidic protein (GFAP), AQP4 and Kir 4.1 as biomarkers of Müller cells activation, by ELISA. ANOVA analysis followed by Tukey-Kramer post-hoc test was applied.

Results: Mean concentration of GFAP, Kir 4.1 and AQP4 significantly decreased in DME eyes versus non DME eyes (p<0.002, for each comparison). Regressing DME eyes showed a significant increase of Müller cells biomarkers compared to persistent DME eyes (p<0.005), never reaching the values of non DME eyes (p< 0.002). AQP4 and Kir 4.1 better represented Müller cells activity (p< 0.001 and < 0.002, in all comparison).

Conclusions: The activation of Müller cells in diabetic retina has been confirmed by the increase of specific biomarkers, even in the aqueous humor. The decrease of Müller cells specific biomarkers in eyes with DME, associated with cystic changes in the middle retina, is a sign of Müller cells degeneration, as previously reported. This study shows that when DME regresses Müller cells activity may be, at least partially, restored, providing the opportunity for retinal recovery in both metabolic and functional activity. These results show that Müller cells activity is critical in the pathophysiology and management of DME.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×